In situ cross-linking of androgen receptors to nuclear acceptor sites of rat prostate with formaldehydeFOEKENS, J. A; RENNIE, P. S; CHENG, H et al.The Journal of biological chemistry (Print). 1985, Vol 260, Num 18, pp 10093-10098, issn 0021-9258Article

Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristicsONSTENK, W; GRATAMA, J. W; FOEKENS, J. A et al.Cancer treatment reviews. 2013, Vol 39, Num 7, pp 691-700, issn 0305-7372, 10 p.Article

Methylated genes as new cancer biomarkersDUFFY, M. J; NAPIERALSKI, R; MARTENS, J. W. M et al.European journal of cancer (1990). 2009, Vol 45, Num 3, pp 335-346, issn 0959-8049, 12 p.Article

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areasFINA, F; ROMAIN, S; BUISSON, M et al.British journal of cancer. 2001, Vol 84, Num 6, pp 783-790, issn 0007-0920Article

Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissueVAN DER FLIER, S; VAN DER KWAST, T. H; CLAASSEN, C. J. C et al.The International journal of biological markers. 2001, Vol 16, Num 3, pp 172-178, issn 0393-6155Conference Paper

Value of estrogenic recruitment before chemotherapy : First randomized trial in primary breast cancerBONTENBAL, M; VAN PUTTEN, W. L. J; VAN DER VELDEN, P. C et al.Journal of clinical oncology. 2000, Vol 18, Num 4, pp 734-742, issn 0732-183XArticle

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancerBERNS, E. M. J. J; FOEKENS, J. A; CORNELISSE, C et al.Cancer research (Baltimore). 2000, Vol 60, Num 8, pp 2155-2162, issn 0008-5472Article

Cathepsin-D in primary breast cancer : prognostic evaluation involving 2810 patientsFOEKENS, J. A; LOOK, M. P; BOLT-DE VRIES, J et al.British journal of cancer. 1999, Vol 79, Num 2, pp 300-307, issn 0007-0920Article

Clinical relevance of the urokinase plasminogen activator system in breast cancerLOOK, M. P; FOEKENS, J. A.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 1999, Vol 107, Num 1, pp 150-159, issn 0903-4641Article

Urokinase-type-plasminogen-activator(UPA) production by human breast (myo)fibroblasts in vitro : Influence of transforming growth FACTOR-β₁ (TGFβ₁) compared with factor(s) released by human epithelial-carcinoma cellsSIEUWERTS, A. M; KLIJN, J. G. M; HENZEN-LOGMANS, S. C et al.International journal of cancer. 1998, Vol 76, Num 6, pp 829-835, issn 0020-7136Article

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extractsSWEEP, C. G. J; GEURTS-MOESPOT, J; BRÜNNER, N et al.British journal of cancer. 1998, Vol 78, Num 11, pp 1434-1441, issn 0007-0920Article

Characterization of mouse urothelial cell lines in different phases of transitional-cell carcinogenesisDE BOER, W. I; REBEL, J. M. J; FOEKENS, J. A et al.International journal of cancer. 1993, Vol 54, Num 6, pp 1022-1027, issn 0020-7136Article

Effects of orchiectomy, alone or in combination with testosterone, and cyproterone acetate on exocrine pancreatic carcinogenesis in rats and hamstersMEIJERS, M; VISSER, C. J. T; KLIJN, J. G. M et al.International journal of pancreatology. 1992, Vol 11, Num 2, pp 137-146, issn 0169-4197Article

Effects of sandostatin and castration on pancreatic carcinogenesis in rats and hamstersMEIJERS, M; WOUTERSEN, R. A; VAN GARDEREN-HOETMER, A et al.International journal of cancer. 1992, Vol 50, Num 2, pp 246-251, issn 0020-7136Article

Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cellsVAN AGTHOVEN, T; VAN AGTHOVEN, T. L. A; PORTENGEN, H et al.Cancer research (Baltimore). 1992, Vol 52, Num 18, pp 5082-5088, issn 0008-5472Article

Effects of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cellsKOPER, J. W; FOEKENS, J. A; BRAAKMAN, R et al.Cancer research (Baltimore). 1990, Vol 50, Num 9, pp 2604-2607, issn 0008-5472, 4 p.Article

The somatostatin analog Sandostatin (SMS201-995) in treatment of DMBA-induced rat mammary tumorsBAKKER, G. H; SETYONO-HAN, B; FOEKENS, J. A et al.Breast cancer research and treatment. 1990, Vol 17, Num 1, pp 23-32, issn 0167-6806, 10 p.Article

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue sandostatin : a phase II study including endocrine effectsKLIJN, J. G. M; HOFF, A. M; PLANTING, A. S. T et al.British journal of cancer. 1990, Vol 62, Num 4, pp 627-630, issn 0007-0920, 4 p.Article

Vitamin D : a modulator of cell proliferation and differentiationPOLS, H. A. P; BIRKENHAGER, J. C; FOEKENS, J. A et al.Journal of steroid biochemistry and molecular biology. 1990, Vol 37, Num 6, pp 873-876, issn 0960-0760, 4 p.Conference Paper

Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumorsBAKKER, G. H; SETYONO-HAN, B; PORTENGEN, H et al.Endocrinology (Philadelphia). 1989, Vol 125, Num 3, pp 1593-1598, issn 0013-7227Article

High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancerJANSEN, M. P. H. M; REIJM, E. A; BERNS, E. M. J. J et al.Breast cancer research and treatment. 2012, Vol 133, Num 3, pp 937-947, issn 0167-6806, 11 p.Article

Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathwaysYANG, F; FOEKENS, J. A; YU, J et al.Oncogene (Basingstoke). 2006, Vol 25, Num 9, pp 1413-1419, issn 0950-9232, 7 p.Article

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistanceLUO, L-Y; DIAMANDIS, E. P; LOOK, M. P et al.British journal of cancer. 2002, Vol 86, Num 11, pp 1790-1796, issn 0007-0920Article

Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumor suppressor geneLOS, M; ZEAMARI, S; FOEKENS, J. A et al.Cancer research (Baltimore). 1999, Vol 59, Num 17, pp 4440-4445, issn 0008-5472Article

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patientsEPPENBERGER, U; KUENG, W; SCHMITT, M et al.Journal of clinical oncology. 1998, Vol 16, Num 9, pp 3129-3136, issn 0732-183XArticle